Registry of Chronic Subdural Hematoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorErasmus Medical Center

About this trial

The goal of this observational study is to better understand how chronic subdural hematoma (CSDH) progresses and how patients are treated and cared for. The study focuses on three main questions:

1. What are the characteristics of patients with CSDH when they are diagnosed? 2. What treatments do patients with CSDH receive? 3. What are the outcomes for patients with CSDH, including their functional ability, cognitive health, and neurological status?

Participants will receive their usual standard treatment. As part of the study, they will complete a brief telephone interview three months after their treatment.

Eligibility criteria

Qualifiers

Patients diagnosed with CSDH

18 years or older

Disqualifiers

Patients who do not consent to participate in the registry

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

1,500 Participants
are grouped into 1 trial group

Sponsors and collaborators